Sudoscan and Cardiovascular outcomes in Hemodialysis
SUDOSCAN in cardiovascular autonomic neuropathy screening
SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020
The utility of SUDOSCAN to diagnose diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy
Impeto Medical is a medical device company part of WITHINGS company. Created in June 2005, its corporate headquarters are located close to Paris, France; the company is also present in San Diego, CA, USA and in Beijing, China.
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12